In developing countries, many tests for infectious diseases never reach the market because there is little financial incentive to pharmaceutical companies to get them there. In this audio interveiw, Alana Conner, senior editor at the Stanford Social Innovation Review, converses with Helen Lee, whose research department at the University of Cambridge has developed tests that allow for the rapid detection—and thus treatment—of diseases in rural settings around the world.